Priti Sinha
- Assistant Clinical Professor, Psychiatry - (Clinical Series Track)
Contact
- (520) 874-4202
- Arizona Health Sciences Center, Rm. 7429
- Tucson, AZ 85724
- psinha@arizona.edu
Degrees
- M.D.
- University of Illinois College of Medicine at Rockford, Rockford, Illinois, United States
Work Experience
- SAVAHCS (2011 - Ongoing)
- University Physician Hospital (currently South Campus) (2008 - 2011)
Awards
- Chief's Teacher of the Year for 2014-2015
- SAVAHCS, Summer 2015
Licensure & Certification
- Board certified in Pyschiatry and Neurology, ABPN (2010)
Interests
Teaching
Psychopharmacology and Telepsychiatry
Courses
No activities entered.
Scholarly Contributions
Journals/Publications
- Sinha, P., & Freeman, M. P. (2007). Tolerability of omega-3 fatty acid supplements in perinatal women.. Prostaglandins, leukotrienes, and essential fatty acids, 77(3-4), 203-8. doi:10.1016/j.plefa.2007.09.004More infoBenefits of omega-3 fatty acids in perinatal women are well documented, although fish intake has declined among perinatal women..To determine the tolerability of omega-3 fatty acid supplementation in perinatal women..Pregnant and postpartum women with major depressive disorder (MDD) entered an 8-week double-blind, placebo-controlled trial of omega-3 fatty acids. Four capsules provided 1.84 g/day of eicosapentanoic acid (EPA) and docosahexaenoic acid (DHA), or matching placebo (corn oil with 1% fish oil to maintain blind). Tolerability was assessed by clinician interview biweekly..Fifty-nine women enrolled. Thirteen (22%) reported mainly transient side effects including dizziness, diarrhea, nausea, burping, heartburn/reflux, difficulty swallowing capsules, unpleasant breath/bad taste or feeling tired. The most common were unpleasant breath/bad taste and heartburn/reflux. Six reporting side effects received omega-3 fatty acids; seven received placebo. Neither pregnant nor postpartum women discontinued due to intolerability..Omega-3 fatty acid supplements were well tolerated by perinatal women.
